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Objectives. This study evaluated the long-term impact of en-
doluminal low power red laser light (LPRLL) on restenosis in an
atherosclerotic rabbit model.
Background. Despite widespread application of balloon angio-
plasty for treatment of coronary artery disease, restenosis limits
its clinical benefits. Restenosis is a complex process and may be
partly attributed to the inability of the vascular endothelium to
regenerate and cover the denuded area at the site of arterial
injury. We previously demonstrated that LPRLL stimulates endo-
thelial cell proliferation in vitro and contributes to rapid endo-
thelial regeneration after balloon injury in nonatherosclerotic
rabbits.
Methods. Rabbit abdominal aortas (n 5 12) were treated in
separate zones with balloon dilation and balloon dilation plus
laser illumination. Endoluminal laser therapy was performed
using a laser-balloon catheter delivering a single dose of 10 mW
for 3 min from a helium-neon laser (632 nm). Angiography was
performed before and after treatment and was repeated 8 weeks
before harvesting the aortas.
Results. Quantitative angiographic analysis demonstrated no
differences in the minimal lumen diameter (MLD) between the
two zones before treatment; an increase in the MLD in both zones
after balloon angioplasty and a significant versus slight reduction
of the MLD in the balloon treatment versus balloon plus laser
zones at 8 weeks. Histologic examination showed a very high level
of myointimal hyperplasia in the balloon treatment zones but a
minimal level in the LPRLL-treated zones. Morphometric analy-
sis revealed a statistically significant difference in the lumen area,
intimal area and intima/media ratio between the balloon versus
balloon plus laser treatment sites.
Conclusions. Our experimental data indicate that endoluminal
irradiation with LPRLL prevents restenosis after balloon angio-
plasty in an atherosclerotic rabbit model.
(J Am Coll Cardiol 1998;31:1152–7)
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The introduction of percutaneous transluminal coronary an-
gioplasty (PTCA) in late 1977 began a new era in the manage-
ment of coronary artery disease, but the frequent occurrence
of restenosis (30% to 50%) significantly limits the long-term
clinical benefits (1,2).
Endothelial cell disruption/dysfunction after coronary ar-
tery intervention may mediate restenosis, suggesting that rapid
regeneration of endothelial cells might impede this process
(3–6). It has been postulated that the process of restenosis has
histologic and pathophysiologic similarities to wound healing
in other living tissues (7–9). Numerous reports indicate that
noncytotoxic doses of low power red laser light (LPRLL)
stimulate in vitro cell proliferation and contribute to tissue
repair (10–12). We previously identified that LPRLL does
enhance endothelial growth as well as attachment in vitro at a
dose that has no effect on smooth muscle cell (SMC) prolifer-
ation (13). In vivo studies in nonatherosclerotic rabbits treated
with balloon angioplasty and endoluminal LPRLL confirmed
the presence of accelerated endothelial regeneration (13,14).
The objective of the present study was to determine the
long-term impact of endoluminal LPRLL on restenosis in an
atherosclerotic rabbit model.
Methods
Experimental animals. Fifteen adult New Zealand White
rabbits weighing 2.5 to 3.5 kg were used in this study. Experi-
mental atherosclerosis was induced by a cholesterol diet and
balloon injury as previously described (15). After 2 weeks of
atherogenic diet, the animals were anesthetized by a mixture of
ketamine (10 mg/kg body weight) and xylazine (1 mg/kg)
administered intravenously and then maintained with pento-
barbital (12 mg/kg intravenously) when required. The femoral
artery was exposed and ligated, and the abdominal aorta was
deendothelialized by a 4F balloon embolectomy catheter
passed via an arteriotomy retrograde into the abdominal aorta
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and withdrawn inflated three times. The animals recovered
from anesthesia and were continued on the atherogenic diet
for 4 weeks before balloon/laser treatment. Rabbits were
fasted overnight before all surgical procedures.
On the day of the second procedure, the marginal ear vein
was cannulated with a 22-gauge angiocatheter and flushed with
heparin to ensure patency. Anesthesia was then induced with a
mixture of ketamine (10 mg/kg) and xylazine (1 mg/kg) admin-
istered as a bolus injection via the marginal ear vein, and then
maintained with pentobarbital (12 mg/kg) given intravenously
as a bolus injection to achieve effect when required. The
abdomen and groin were shaved and the skin cleaned for the
operation using betadine. The abdomen was opened and the
abdominal aorta carefully exposed from the iliac bifurcation to
an area adjacent to the renal arteries. Two treatment zones
2 mm in length averaging 2.7 to 3.5 mm in diameter were
identified by placing a fine prolene stitch in the adventitia. In
addition, the distance from each stitch to the iliac bifurcation
was measured and recorded.
Animals used in this study received humane care in com-
pliance with the “Principles of Laboratory Animal Care”
formulated by the National Society for Medical Research and
the “Guide for the Care and Use of Laboratory Animals”
prepared by the National Academy of Sciences and published
by the National Institutes of Health (NIH publication No.
85-23, revised 1985).
Experimental protocol. Two treatment zones of 2.0 cm in
length, each within the abdominal aorta, were identified with
prolene stitches as described previously. All catheters were
advanced using a 4F or 5F pediatric introducer sheath through
a small incision in the femoral artery. The introducer catheter
was continuously flushed (1 to 2 ml/min) with lactated Ringer’s
solution. Immediately before introducing the catheters, hepa-
rin (1,000 IU) was administered through the introducer cath-
eter as a bolus injection. Each zone was subjected to one of the
following treatments: 1) Balloon dilation alone, in a selected
aortic segment with 1.1:1 balloon/vessel ratio using three cycles
of inflation to 8 atm pressure for 30 s, followed by one cycle of
inflation to 2 atm for 180 s using a laser-balloon catheter. 2)
Balloon dilation plus laser illumination. Three cycles of infla-
tion to 8 atm for 30 s each, followed by laser illumination.
Endoluminal LPRLL therapy was performed using a laser-
balloon catheter with a 200 mm fiberoptic with a diffuse tip at
the end to provide a uniform distribution of light in the radial
and axial directions of the balloon (Fig. 1). In all animals a
single dose of 10 mW was given for 180 s generated from a
helium-neon laser (wavelength 632 nm). During illumination
the balloon was inflated with a mixture of nonionic contrast
and saline to 2 atm.
The anatomic order of each treatment site was systemati-
cally rotated to avoid any inherent bias. Angiography was
performed in all animals immediately before and after balloon-
laser treatment and was then repeated 8 weeks before harvest-
ing the aortas for tissue processing. After treatment, the
catheter was removed and the site of the catheter introduction
repaired with one stitch using a prolene suture. The skin was
closed and the animals allowed to recover. Antibiotics were
given as necessary. Twelve animals recovered from the second
procedure and were kept on atherogenic diet for an additional
8 weeks.
Tissue processing. The animals were then reanesthetized
and heparinized, the abdomen opened, and the abdominal
aorta exposed to identify the marking tags.
The animals were euthanized to ensure blood was not
delivered to the abdominal aorta. The aorta was then cannu-
lated proximal to the treatment zones. The iliac arteries were
severed and all side branches of the abdominal aorta ligated.
The entire vessel was then flushed in vivo with >100 ml
phosphate-buffered saline to remove blood from the lumen of
the vessel. This was followed with >100 ml of 10% buffered
formalin. The aorta was then fixed at hydrostatic pressure
(80 mm Hg) for 30 min using 10% buffered formalin. Follow-
ing fixation, the artery was dissected to reveal the two treat-
ment zones. This procedure was designed 1) to minimize the
generation of artifacts and to preserve the normal diameter
and length of the vessel, and 2) to avoid a potentially bloody
dissection during harvest by enabling the fixed vessel to be
dissected out from a dead animal.
Tissue staining. Each vessel was serially sectioned in 2-mm
increments to produce a minimum of nine 4-mm cross-sections.
Following embedding in paraffin and dehydration, the sections
were stained for light microscopic analysis with the following
agents: 1) hematoxylin and eosin, 2) Movatt’s elastic tissue
pentachrome, 3) smooth muscle cell actin, and 4) proliferating
cell nuclear antigen.
Analysis of data. The areas of lumen, intimal hyperplasia
and media were determined using a Tamaya Digital Planime-
ter (Lietz, Overland Park, KS) in all zones at 8 weeks after
Abbreviations and Acronyms
LPRLL 5 low power red laser light
MLD 5 minimal lumen diameter
PTCA 5 percutaneous transluminal coronary angioplasty
SMC 5 smooth muscle cell
Figure 1. Laser-balloon catheter. Note the homogenous diffuse char-
acter of laser irradiation.
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treatment. From this data the ratio of the total intimal area to
the total medial area was derived.
In addition, the two treatment zones were analyzed histo-
logically in a blinded fashion by two cardiac pathologists.
The angiographic data were analyzed for changes in luminal
diameter for all treatment zones immediately before and after
laser/balloon treatment and 8 weeks later before harvest of the
vessels. Quantitative analysis of angiograms was performed on
all vessels. Two observers, in blinded manner, recorded the
diameter of each treatment zone by tracing the original image
of the video recordings onto clear transparent sheets. This
method is reproducible within 0.2 mm in our laboratory. For
all treatment sites the minimal lumen diameter (MLD), the
percent of stenosis in comparison with an inflated balloon as an
internal standard was determined. From these data acute gain
and late loss were derived.
Statistical analysis. Data (mean value 6 SD) were ana-
lyzed for overall differences between treatment groups by
Student t test, incorporating the Bonferroni correction for
multiple comparisons. Comparison of the mean values with a p
value of ,0.05 was considered statistically significant. Corre-
lation analysis was then performed between all measured
variables using Pearson product moment analysis as well as
Spearman rank order correlation analysis.
Results
Quantitative angiographic analysis. Quantitative angio-
graphic analysis in 12 animals demonstrated that there were no
differences in MLD between the balloon zone (1.82 6
0.09 mm) and balloon plus laser zone (1.85 6 0.10 mm) before
treatment (Table 1). Balloon angioplasty resulted in an in-
crease in MLD in both balloon alone and balloon plus laser
treatment sites to 2.53 6 0.43 mm and 2.46 6 0.46 mm,
respectively. An acute gain in lumen diameter (defined as the
difference in predilation and postdilation MLD) was present in
both the balloon group (0.71 6 0.06 mm) and the balloon plus
laser group (0.61 6 0.24 mm).
Angiography was then repeated at 60 days immediately
before vessel harvest and revealed a significant reduction of
MLD at the balloon treatment sites (1.62 6 0.16 mm). By
contrast, the MLD of sites subjected to endoluminal laser
therapy after balloon dilation was only slightly reduced (2.32 6
0.06 mm) (Fig. 2).
Late loss (defined as the difference between MLD at the
time of harvest and after dilation) ranged from 0.91 6 0.05 mm
in the balloon group to 0.14 6 0.04 mm in the balloon plus
laser group (p , 0.05 balloon vs. balloon plus laser). In the
balloon group there was a significant correlation between acute
gain and late loss (r 5 0.47, p , 0.05); in the laser-treated
arteries there was no correlation between acute gain and late
loss (r 5 0.04, p . 0.05).
Pathologic analysis. The angiographic findings also were
reflected in the pathologic analysis based on histologic and
morphometric criteria. Histologic examination of the extent of
medial necrosis did not show any differences between treat-
ment sites. There was a significant difference, however, in the
level of myointimal hyperplasia. In the specimens obtained
from balloon treatment locations we observed a very high level
of myointimal hyperplasia. Interestingly, hyperplasia was con-
centric with a large number of SMCs. By contrast, the speci-
mens subjected to endoluminal irradiation with LPRLL dem-
onstrated minimal, eccentrically situated zones of myointimal
hyperplasia (Fig. 3).
Morphometric analysis demonstrated that intimal area was
five times greater in the areas subjected to balloon treatment
alone (25.3 6 1.9 mm2) than in the balloon plus laser treat-
ment sites (4.2 6 0.7 mm2) (Table 2). Also there was a
statistically significant difference (p , 0.05) in the luminal
area, intimal area and intima/media ratio between the two
treatment sites.







MLD before treatment (mm) 1.82 6 0.09 1.85 6 0.10*
MLD after balloon angioplasty (mm) 2.53 6 0.43 2.46 6 0.46*
MLD before harvest (mm) 1.62 6 0.16 2.32 6 0.06†
Acute gain (mm) 0.71 6 0.06 0.61 6 0.24*
Late loss (mm) 0.91 6 0.05 0.14 6 0.04†
Net gain (mm) 20.2 6 0.01 0.47 6 0.12*
Loss index 1.28 6 0.21 0.22 6 0.02*
*p . 0.05, †p , 0.05 for balloon versus balloon plus laser. Data presented
are mean value 6 SD. MLD 5 minimal lumen diameter.
Figure 2. Angiogram of rabbit aorta at 8 weeks after treatment before
harvest. Note that the distal portion of the abdominal aorta subjected
to balloon angioplasty is restenosed. The midportion of the abdominal
aorta subjected to balloon angioplasty and endoluminal LPRLL
irradiation is widely open, without significant reduction of the lumen.
B 5 balloon angioplasty; L 5 balloon angioplasty plus endoluminal
laser.
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Figure 3. Impact of endoluminal LPRLL on resten-
osis at 8 weeks after treatment. A, Low magnification
image of histologic cross section of rabbit abdominal
aorta subjected to balloon angioplasty. Note the
significant reduction of lumen area with marked
intimal hyperplasia. Hematoxylin-eosin stain. B, Low
magnification image of histologic cross section of
rabbit abdominal aorta subjected to balloon angio-
plasty and endoluminal laser irradiation. Note the
minor intimal growth with near normal lumen area.
Hematoxylin-eosin light stain. C, Higher magnifica-
tion of histologic cross section of rabbit aorta sub-
jected to balloon angioplasty and endoluminal laser
irradiation shows endothelial cell regeneration and
mild SMC proliferation. Movatt’s stain. E 5 endo-
thelium; I 5 intima; L 5 lumen, M 5 media.
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Discussion
We demonstrated both angiographically and histologically
that endoluminal laser irradiation of postangioplasty zones is
capable of reducing the degree of myointimal hyperplasia at 60
days following balloon dilation in an atherosclerotic rabbit
model.
The effect of LPRLL was previously studied in vivo using
the balloon injury model in normal rabbit iliac arteries (13).
Quantitative analysis identified significant enhancement of
re-endothelialization following intravascular LPRLL irradia-
tion. Ultrastructural analysis of vascular segments using
scanning electron microscopy confirmed these results. Endo-
thelialization originated from the proximal and distal ends
of the injured segments in control arteries. By contrast,
re-endothelialization was homogenous throughout the vessel
in the laser-treated arteries. Moreover, there was less platelet
adhesion and less macrophage deposition in the laser-treated
vessels.
The mechanisms by which laser light enhances endothelial
repair were further evaluated in vitro by studying the adhesive
properties of endothelial cells and their rate of regeneration
(16). We show that stimulation or inhibition (or both) of cell
proliferation in vitro can each be obtained with LPRLL by
varying the energy level. These data correlate with other
reports. It is recognized that LPRLL is capable of influencing
cellular behavior (cell growth, differentiation, motility, migra-
tion and phagocytosis) in the absence of significant thermal
effect (10,16–21). In our experiments endothelial cells were
more sensitive to photobiomodulation with LPRLL then were
SMCs. SMCs were more resistant to LPRLL, however, al-
though a higher dose of LPRLL was cytotoxic for both
endothelial cells and SMCs. We also observed that low doses
of light significantly increased the attachment efficacy of endo-
thelial cells. Similar results were reported by Karu et al. (11).
They demonstrated that LPRLL stimulates adhesion of He-La
cells in vitro and speculated that visible light alters the intensity
of ion fluxes through the cell membrane, which may enhance
cell sedimentation and adhesion. Functional behavior of tumor
cells, however, is not as dependent on attachment and adhe-
sion, whereas endothelial cells require attachment before
proliferation (22).
Integrins are major receptors that mediate adhesive inter-
actions in living tissue. They are intimately involved in the
regulation of many cellular functions, including programmed
cellular death, hemostasis-thrombosis, leukocyte activation
and the response of cells to mechanical injury (23). Integrins
can trigger several signal transduction pathways and regulate
changes in gene expression critical for proliferative response
and affinity of membrane to growth factors. Experimental
balloon angioplasty rarely results in complete denudation of
endothelium. Based on in vitro (enhancement of cell adhesion)
and in vivo (homogenous endothelialization of entire segment)
findings, we believe that intravascular laser therapy may trigger
integrin-dependent pathways of preserved endothelium that
signal increased DNA synthesis. This results in endothelial cell
proliferation. We investigated this hypothesis by determining
the rate of (H3) thymidine uptake in confluent endothelial cell
cultures (unpublished data). Low doses of red light increased
DNA synthesis by 45.5% 6 6.8%. At higher doses, DNA
synthesis diminished, consistent with a cytotoxic effect of
higher dose therapy.
In summary, we found that endoluminal LPRLL after
balloon angioplasty stimulates endothelial regeneration,
thereby enhancing vascular healing before a hemodynamically
important reduction in arterial lumen area can take place. This
results in a decreased rate of restenosis.
Although the mechanisms by which this might occur have
not yet been established, stimulation of endothelial repair with
LPRLL may be mediated by integrin-dependent pathways that
in turn prevent migration of SMCs into media as well as
reduction of platelet activation and vascular reactivity (24–26).
Study limitations. Our data support the idea of beneficial
effects of endoluminal LPRLL on restenosis; however, certain
limitations of the present study must be acknowledged. First, is
the small animal model, with the principal disadvantages of the
atherosclerotic rabbit model, including the morphologic differ-
ences from human lesions; second, and perhaps more impor-
tantly, is that the biologic mechanism of action of LPRLL on
the vascular wall needs further exploration. Furthermore,
additional studies are required to access function and biologic
activity of regenerated endothelium.
Conclusions. Our experimental data indicate that endolu-
minal irradiation with LPRLL prevents restenosis after balloon
angioplasty in an atherosclerotic rabbit model. Endoluminal
LPRLL therapy may have a significant role in interventional
cardiology, not only to prevent restenosis after coronary inter-
ventions but also to stabilize vascular endothelium so that
progression or redevelopment of the disease is inhibited.
Randomized studies are required to establish this as an
effective clinical tool in humans.
We are grateful to John R. Petersen, MD for review of the manuscript.
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